Tuberculous iridocyclitis
ICD-10 A18.54 is a billable code used to indicate a diagnosis of tuberculous iridocyclitis.
Tuberculous iridocyclitis is an inflammatory condition of the eye characterized by the involvement of the iris and ciliary body due to Mycobacterium tuberculosis infection. This condition can occur as a part of systemic tuberculosis or as an isolated ocular manifestation. Patients may present with symptoms such as redness, pain, photophobia, and blurred vision. Diagnosis typically involves a thorough clinical examination, including slit-lamp examination, and may be supported by ancillary tests such as tuberculin skin tests, interferon-gamma release assays, and imaging studies like chest X-rays to assess for pulmonary involvement. Treatment often includes antituberculous therapy, which may involve a combination of isoniazid, rifampicin, ethambutol, and pyrazinamide, tailored to the patient's specific needs and drug susceptibility patterns. Monitoring for drug resistance is crucial, as multidrug-resistant tuberculosis can complicate treatment. Public health implications are significant, necessitating contact tracing and isolation procedures for infectious cases to prevent transmission. Regular follow-up is essential to assess treatment response and manage any complications.
Detailed clinical notes on ocular examination findings, treatment plans, and follow-up assessments.
Patients presenting with uveitis symptoms, especially in endemic areas for tuberculosis.
Need for collaboration with infectious disease specialists for comprehensive management.
Comprehensive history of tuberculosis exposure, treatment regimens, and monitoring for drug resistance.
Patients with systemic tuberculosis presenting with ocular symptoms.
Coordination of care with ophthalmology for integrated treatment approaches.
Used for initial evaluation of a patient presenting with symptoms of iridocyclitis.
Complete eye examination findings, including visual acuity and intraocular pressure.
Ophthalmologists should document any systemic evaluations performed.
Common symptoms include eye pain, redness, photophobia, and blurred vision. Patients may also experience systemic symptoms related to tuberculosis.
Diagnosis is made through clinical examination, history of tuberculosis exposure, and supportive tests such as skin tests and imaging studies.
Treatment typically involves a multi-drug regimen for tuberculosis, including isoniazid, rifampicin, ethambutol, and pyrazinamide, with careful monitoring for drug resistance.
